2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine has been researched along with 2-nitro-3-methylimidazo(4,5-f)quinoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kristiansen, E | 1 |
| Hayashi, M; Itoh, T; Kuwahara, T; Ohnishi, Y; Suzuki, T | 1 |
2 other study(ies) available for 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine and 2-nitro-3-methylimidazo(4,5-f)quinoline
| Article | Year |
|---|---|
The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) in the development of colon cancer in mice.
Topics: Animals; Carcinogens; Colon; Colonic Neoplasms; Female; Imidazoles; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Precancerous Conditions; Quinolines | 1996 |
Regional mutagenicity of heterocyclic amines in the intestine: mutation analysis of the cII gene in lambda/lacZ transgenic mice.
Topics: Amines; Animals; Bacteriophage lambda; Carbolines; Colon; Heterocyclic Compounds; Imidazoles; Intestine, Small; Intestines; Lac Operon; Male; Mice; Mice, Transgenic; Mutagenicity Tests; Mutagens; Quinolines; Transcription Factors; Viral Proteins | 2003 |